Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Kaja Kiiver
Introduction
Kaja Kiiver, an accomplished inventor located in Tartu, Estonia, has made significant strides in the field of immunology through her innovations. With a focus on developing efficient adjuvants for vaccines, her contributions are paving the way for enhanced immune responses in subjects receiving immunization.
Latest Patents
Kaja Kiiver holds a notable patent titled "Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant." This invention involves an alphaviral replicase, particularly the Semliki Forest Virus replicase, which functions as an immune system modulating adjuvant. The application of this replicase is intended to increase the efficacy of vaccines by providing an additional boost to the immune response when administered in combination with a vaccine compared to the vaccine alone. The primary aim is to develop a user-friendly, species-independent adjuvant that surpasses the traditional adjuvants currently in use.
Career Highlights
Throughout her career, Kaja Kiiver has demonstrated a commitment to advancing the field of biotechnology. Her position at Fit Biotech Oy underscores her role in a company dedicated to innovative solutions in the biotechnology sector. With a focus on developing novel biopharmaceuticals, her contributions align with the company’s mission to enhance health outcomes through innovation.
Collaborations
Kaja works alongside talented colleagues, including Rein Sikut and Urve Toots, who also contribute to the innovative culture at Fit Biotech Oy. The collaborative environment fosters creativity and the sharing of ideas, driving the development of groundbreaking biotechnological advancements.
Conclusion
Kaja Kiiver is a remarkable inventor whose work on alphavirus replicase represents a significant innovation in the biotechnology realm. Her commitment to research and development at Fit Biotech Oy showcases her dedication to improving vaccine efficacy. As she continues to explore new horizons in immunology, her inventions will undoubtedly have lasting impacts on public health.